Product Code: RP-ID-10008244 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10008244
Market Overview:
Global In Vitro fertilization Market Size, Growth, Opportunity and Forecast 2022-2030
" The Global In Vitrofertilization (IVF) market is estimated to be valued at ~USD 16 billion by end of 2021 and is projected to expand at a CAGR of ~7% from 2022 to 2030. One of the most important and market drivers of growth is: Born tourism. Incidence of infertility in men and women.Childbirth is one of the biggest health problems for people around the world. According to the American Pregnancy Association, male infertility cases account for 30.0% of infertility cases and about one fifth of infertility cases. Also, literate women prefer to plan family plans later for career guidance. This makes women more dependent on infertility treatment as fertility decreases with age.
In vitro fertilization (IVF) method. In December 2016, the Ontario government announced a $50 million birth program that would cover $50 million in IVF treatment. Additionally, the Singapore government has provided approximately 75% of total funding for various ART procedures such as in vitro fertilization, playful fallopian tube transplantation (GIFT) and intracytoplasmic sperm injection (ICSI). In January 2015, the US Centers for Disease Control and Prevention (CDC) reported that the use of ICSI for new product development increased from 36.4% in 1996 to approximately 76.2% (and TESE) in 2012.
In June 2018, Australian scientists used an artificial intelligence tool called Ivy to determine which fetus is most likely to conceive. These technologies have helped increase IVF pregnancy success rates as the COVID-19 pandemic hampers infertility treatment and women give up mental illness.
A study published by the American Society for Reproductive Medicine found that restrictions on COVID-19 were relaxed, with about 62% of participants wanting to start treatment by October 2020. Medical centers can begin effective treatment immediately if certain guidelines are followed. The Human Reproductive and Embryology Organization has issued a permit to resume treatment in June 2020.
INSTRUMENT INFORMATION:
The cultural media sector dominates the IVF market and will account for the largest revenue share in 2020, exceeding 38%, due to the availability of funds and increased research activities to strengthen cultural media. However, as industry players introduce disposable devices such as needles, slides, and chambers to meet sterility and regulatory requirements, the disposable device segment is expected to grow at the fastest rate in the next few years.
PROCEDURAL INFORMATION:
The fresh non-donor segment dominates the IVF market and will account for the highest revenue share of 40% in 2020. This increase is due to the high first attempt success rate of the program. Since this procedure can be performed even in complex situations, this segment of the market may achieve the fastest growth in the next few years. For example, patients with ovarian hyperstimulation syndrome (OHSS) may choose this type of IVF surgery.
END USE INSIGHT:
The fertility clinic sector dominates the IVF market and will account for approximately 77% of the largest revenue share in 2020, and may dominate the entire forecast period. As the demand for ART treatment increases, the number of fertility clinics and ART centers has also increased significantly. Factors such as cost-effectiveness, availability of specialists, and little or no possibility of hospital-acquired infections are some of the key factors attributable to the growth of fertility clinics.
REGIONAL INFORMATION:
Due to factors such as medical tourism and legal reviews related to IVF technology, Europe dominates the IVF market and will account for the largest revenue share in 2020 at 37.0%. More and more Americans are heading to the Czech Republic to enjoy low-cost IVF treatment.
KEY COMPANIES AND MARKET SHARE PROSPECTS:
Geographic expansion, mergers, and product innovation and commercialization are key strategies for market participants to operate in the market. In July 2019, Vitrolife and Prime Tech signed a cooperation agreement to design and commercialize piezoelectric technology to improve intracytoplasmic sperm for human IVF on a global scale (except Thailand, Japan, and Malaysia) Injection (ICSI) procedure. Some of the major players in the IVF market include: OvaScienceEMD Serono Inc. Vitrolife ABIrvine ScientificCook Medical Inc Cooper Surgical Inc. Genea Biomedx Thermo Fisher Scientific Inc. Progyny, Inc. Boston IVF
MARKET SEGMENTS COVERED BY THE REPORT :
The report forecasts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research will report on the global IVF market based on instrument, procedure type, end use, and region: Instrument Outlook (Revenue, USD Million, 2022-2030) Medium-sized Disposable Equipment Cultivation Equipment Capital Equipment Procedure Type Outlook (income, USD million, 2022-2030) Fresh donors, frozen donors, non-fresh donors, non-frozen donors, end-use outlook (income, USD million, 2022-2030) Fertility clinics, hospitals and other environments. "
1. Coopersurgical Inc. (A Subsidiary of the Cooper Companies, Inc.)
2. Vitrolife AB
3. Cook Medical Inc.
4. Irvine Scientific
5. Thermo Fisher Scientific Inc.
6. EMD Sereno Inc. (Merck KGaA)
7. Genea Limited
8. Esco Micro Pte. Ltd.
9. IVFtech APS
10. The Baker Company, Inc.
11. Kitazato Corporation
12. Rocket Medical PLC.
Related Reports
Proof of Quality & Reliability
